161 related articles for article (PubMed ID: 19879464)
1. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction.
Kaneko H; Anzai T; Naito K; Kohno T; Maekawa Y; Takahashi T; Kawamura A; Yoshikawa T; Ogawa S
J Card Fail; 2009 Nov; 15(9):775-81. PubMed ID: 19879464
[TBL] [Abstract][Full Text] [Related]
2. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
[TBL] [Abstract][Full Text] [Related]
3. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
[TBL] [Abstract][Full Text] [Related]
5. [Attenuation of reperfusion phenomenon by reperfusion using leukocyte-depleted blood during direct percutaneous transluminal coronary angioplasty for acute myocardial infarction].
Watanabe S; Iseki H; Tanaka K; Ishibashi H; Tanaka K; Takei Y; Ejiri N
J Cardiol; 1999 Mar; 33(3):145-52. PubMed ID: 10225194
[TBL] [Abstract][Full Text] [Related]
6. Early sustained ventricular arrhythmias complicating acute myocardial infarction.
Piccini JP; Berger JS; Brown DL
Am J Med; 2008 Sep; 121(9):797-804. PubMed ID: 18724970
[TBL] [Abstract][Full Text] [Related]
7. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes.
Mehta RH; Harjai KJ; Grines L; Stone GW; Boura J; Cox D; O'Neill W; Grines CL;
J Am Coll Cardiol; 2004 May; 43(10):1765-72. PubMed ID: 15145097
[TBL] [Abstract][Full Text] [Related]
8. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
9. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
11. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
12. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
14. Impact of systemic acidosis on the development of malignant ventricular arrhythmias after reperfusion therapy for ST-elevation myocardial infarction.
Nagai T; Anzai T; Kaneko H; Anzai A; Mano Y; Nagatomo Y; Kohsaka S; Maekawa Y; Kawamura A; Yoshikawa T; Ogawa S
Circ J; 2010 Sep; 74(9):1808-14. PubMed ID: 20606327
[TBL] [Abstract][Full Text] [Related]
15. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
[TBL] [Abstract][Full Text] [Related]
16. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Apr; 85(4):1278-81. PubMed ID: 18355509
[TBL] [Abstract][Full Text] [Related]
17. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
19. Transient ST-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction.
Meisel SR; Dagan Y; Blondheim DS; Dacca S; Shochat M; Kazatsker M; Asif A; Frimerman A; Shotan A
Am Heart J; 2008 May; 155(5):848-54. PubMed ID: 18440331
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
